US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.590
  • -0.060-3.63%
Trading Dec 12 10:53 ET
183.20MMarket Cap-17.67P/E (TTM)

About Coherus BioSciences Company

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Company Profile

SymbolCHRS
Company NameCoherus BioSciences
Listing DateNov 6, 2014
Issue Price13.50
Founded2010
CEOMr. Dennis M. Lanfear
MarketNASDAQ
Employees306
Fiscal Year Ends12-31
Address333 Twin Dolphin Drive,Suite 600
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-649-3530
Websitehttp://www.coherus.com

Company Executives

  • Name
  • Position
  • Salary
  • Dennis M. Lanfear
  • President, Chief Executive Officer and Chairman of the Board
  • 5.90M
  • Bryan J. McMichael
  • Chief Financial Officer and Principal Accounting Officer
  • 1.07M
  • Paul Reider
  • Chief Commercial Officer
  • 1.93M
  • Rita A. Karachun
  • Director
  • --
  • Georgia L. Erbez
  • Director
  • --
  • Dr. Michael Ryan, Pharm.D.
  • Director
  • 173.61K
  • Mark D. Stolper
  • Independent Director
  • 198.69K
  • Mats L. Wahlstrom
  • Lead Independent Director
  • 228.69K
  • Kimberly J. Tzoumakas
  • Independent Director
  • 193.69K
  • Charles Newton
  • Independent Director
  • 188.69K
  • Ali J. Satvat
  • Independent Director
  • 65.00K
  • Dr. Lee N. Newcomer, M.D.
  • Independent Director
  • 186.19K
  • Dr. Jill O’Donnell-Tormey
  • Independent Director
  • 183.69K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Microsoft
MSFT
+1.33%
MARA Holdings
MARA
+0.77%
Coinbase
COIN
+0.53%
Apple
AAPL
+0.60%
Salesforce
CRM
+0.43%

Unlock the Full List